Allergan, Inc.

Jaya Giyanani

Anuradha V Gore

Chetan Pujara

John T Trogden

Adnan K Salameh

Michael R Robinson

Rhett M Schiffman

Mohammed I Dibas

Mayssa Attar

Aileen Morgan

Jihao Zhou

Sungwook Lee

Ronald Bradford

Andrea S Kim

Haixia Liu

Sukhon Likitlersuang

Chetan P Pujara

Mohammed Dibas

Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.

Presbyopia treatments

The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions.

Androgen composition for treating an ophthalmic condition

Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Non-irritating testosterone emulsions

Stabilized ophthalmic compositions containing omega-3 oils are provided, which are useful as artificial tears and as ophthalmic compositions to diagnose, treat, or prevent keratoconjunctivitis or dry eye syndrome in a human or other mammal.

Stabilized omega-3 ophthalmic compositions

Androgen composition for treating an opthalmic condition

Growing community of inventors

Irvine, CA, United States of America

Jaya Giyanani